Ospedale San Gerardo
Monza, MB, 20900, Italy
NCT Number: NCT05597319
Enhanced Recovery After Surgery (ERAS) Program (EP) is widely applied to obtain a reduction in post-operative length of hospital stay and a faster restoration of pre-operative patient conditions. However, in Western countries, adherence to EP in liver surgery is still difficult to achieve due to deep-rooted traditional practices. In our Institute, since 2019, EP has been applied pursuing 18/23 items identified by 2016 guidelines. At all consecutive patients who underwent elective liver surgery in our Institution, EP was proposed and their adherence to ERAS items was measured before, during and after surgery. Data were retrospectively collected and analysed, particularly focusing on EP items. Primary outcome was compliance to EP, defined as at least 80% of accomplished items per patient. Secondary outcome was adherence to each ERAS item, while tertiary outcome was detecting the variables associated with program drop out.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Monza, MB, 20900, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Liver resection, different kind of according to pathology
Time frame: 32 months
Compliance to ERAS program was defined as at least 80% of accomplished items per patient
Time frame: 32 months
Compliance to each ERAS item singularly
Time frame: 32 months
Determining factors associated with ERAS program drop-out
University of Milano Bicocca
Other
Enhanced Recovery After Surgery: Compliance to the Program in Liver Surgery and Factors Associated With Drop-out
Acronym: ERASliver
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07199478
ERAS, Total Hip Arthroplasty
Luzhou, Sichuan, China
View Trial DetailsNCT07232394
ERAS, Lung Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT05962320
Anxiety Disorders, Appendicitis
Trabzon, Turkey (Türkiye)
View Trial DetailsNCT06424938
Agnosia, Analgesia
Istanbul, Turkey (Türkiye)
View Trial Details